Search

Insulet Corp

Closed

SectorHealthcare

147.94 5.97

Overview

Share price change

24h

Current

Min

138.15

Max

143.3

Key metrics

By Trading Economics

Income

3.9M

95M

Sales

40M

802M

P/E

Sector Avg

26.751

57.002

EPS

1.66

Profit margin

11.85

Employees

5,400

EBITDA

-22M

132M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+21.7% upside

Dividends

By Acuity

Next Earnings

5 Nov 2026

Market Stats

By TradingEconomics

Market Cap

-1.8B

9.9B

Previous open

141.97

Previous close

147.94

News Sentiment

By Acuity

75%

25%

310 / 340 Healthcare

Insulet Corp Chart

Past performance is not a reliable indicator of future results.

Related News

17 Aug 2026, 20:06 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities law violations related to safety risks in manufacturing processes.

14 Aug 2026, 20:06 UTC

News

Insulet Corp faces a securities fraud class action lawsuit from Levi & Korsinsky, LLP, contributing to a decline in shares during regular trading hours.

13 Aug 2026, 23:06 UTC

Insulet Corp shares are lower in after-market hours, with no specific news identified to explain the decline. The stock remains near the middle of its one-month range.

12 Aug 2026, 19:36 UTC

Insulet Corp shares are higher during Wednesday's session, recovering from earlier lows. Broader market inflation data may be supporting positive sentiment.

11 Aug 2026, 19:46 UTC

Insulet Corp's shares are higher, continuing a four-session trend, despite no specific news. Market participants are reacting to recent economic indicators and Fed rate expectations.

10 Aug 2026, 22:56 UTC

News

Insulet Corp shares are lower in after-market trading following a class action lawsuit from Pomerantz LLP alleging false statements about manufacturing practices and product safety.

7 Aug 2026, 19:36 UTC

News

Insulet Corp shares are higher as Deutsche Bank initiates coverage with a "buy" rating and a $190 price target, despite a downgrade from Oppenheimer.

6 Aug 2026, 23:32 UTC

News

Insulet Corp shares are lower in after-market hours following a downgrade to Market Perform by Leerink Partners and a reduced price target of $145.

5 Aug 2026, 23:46 UTC

Insulet Corp. shares traded lower in after-market hours, reflecting routine activity and cautious market sentiment amid disappointing private sector employment data.

4 Aug 2026, 23:56 UTC

Insulet Corp shares are lower in after-market hours, showing little change since Tuesday's close amid a lack of specific company news.

3 Aug 2026, 19:36 UTC

Correlated Moves

Insulet Corp's shares are higher today, supported by a positive trend in the medical devices sector. The stock remains above its 20-day moving average.

31 Jul 2026, 20:06 UTC

News

Insulet Corp shares are declining amid a securities class action lawsuit alleging misrepresentations about the safety of its Omnipod products.

29 Jul 2026, 18:43 UTC

Insulet Corp shares are higher, driven by gains in the Health Care Equipment sub-sector. The stock remains well above its 20-day moving average.

28 Jul 2026, 19:06 UTC

Correlated Moves

Insulet Corp shares are trading higher, benefiting from a significant rise in the Health Care Equipment sub-sector and ongoing momentum above their 20-day moving average.

27 Jul 2026, 20:06 UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

24 Jul 2026, 22:26 UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

22 Jul 2026, 20:01 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities fraud related to safety claims about its Omnipod products.

20 Jul 2026, 18:36 UTC

News

Insulet Corp is gaining today after being identified as a healthcare stock likely to deliver sustainable market-beating returns, despite ongoing legal challenges.

Peer Comparison

Price change

Insulet Corp Forecast

Price Target

By TipRanks

21.7% upside

12 Months Forecast

Average 174.45 USD  21.7%

High 216 USD

Low 144 USD

Based on 23 Wall Street analysts offering 12 month price targets forInsulet Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

23 ratings

13

Buy

9

Hold

1

Sell

Sentiment

By Acuity

310 / 340 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat